Intensity Therapeutics, Inc.
INTS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $10 | $6 | $30 | $26 |
| - Cash | $7 | $2 | $1 | $3 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $3 | $4 | $29 | $23 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | -$3 | -$3 | -$3 |
| % Margin | – | – | – | – |
| Net Income | -$3 | -$3 | -$3 | -$3 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.06 | -0.13 | -0.22 | -0.22 |
| % Growth | 53.8% | 40.9% | 0% | – |
| Operating Cash Flow | -$2 | -$2 | -$2 | -$3 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2 | -$2 | -$2 | -$3 |